Detrimental effect of hydrosalpinx fluid on the development and blastulation of mouse embryos in vitro

Fertility and Sterility

Volumn 68, Issue 3, 1997, Pages 531-533

  Sachdev, Rahul ^a   Kemmann, Ekkehard ^a   Bohrer, Michael K ^a   El Danasouri, Iman ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Embryotoxicity; Hydrosalpinx; In vitro fertilization

Indexed keywords

ANIMAL TISSUE; ARTICLE; BLASTULA; CONTROLLED STUDY; CYST FLUID; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; FEMALE INFERTILITY; HUMAN; HYDROSALPINX; LAPAROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE TUBE TUMOR;

ANIMALS; BLASTOCYST; FALLOPIAN TUBE DISEASES; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; PREGNANCY;

EID: 0030769640     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)00238-0     Document Type: Article

References (16)

1. Alt KA, Faro S. Pelvic inflammatory disease: current diagnostic criteria and treatment guidelines. Postgrad Med 1993;93:85-6,89-91.
2. Gibson M, Gump D, Ashikaga T, Hall B. Patterns of adnexal inflammatory damage: chlamydia, the intrauterine device, and history of pelvic inflammatory disease. Fertil Steril 1984;41:47-51.
3. Westrom L, Wolner-Hanssen P. Pathogenesis of pelvic inflammatory disease. Genitourin Med 1993;69:9-17.
4. Reich H. Laparoscopic treatment of extensive pelvic adhesions, including hydrosalpinx. J Reprod Med 1987;32:736-42.
5. Boer-Meisel ME, te Velde ER, Kardaun JW. Predicting the pregnancy outcome in patients treated for hydrosalpinx: a prospective study. Fertil Steril 1986;45:23-9.
6. Kassabji M, Sims JA, Butler L, Muasher SJ. Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 1994;56:129-32.
7. Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:861-3.
8. Vandromme J, Chasse E, Lejune B, Van Rysselberge M, Delvigne A, Leroy F. Hydrosalpinges in in-vitro fertilization: an unfavorable prognostic feature. Hum Reprod 1995;10:576-9.
9. Monsour RT, Aboulghar MA, Sevour B, Sarov GI, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation. J In Vitro Fert Embryo Transfer 1991;8:157-9.
10. Anderson AN, Yue Z, Meng FJ, Petersen K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 1994;9:1935-8.
11. Fleming C, Hull MGR. Impaired implantation after in vitro fertilisation treatment associated with hydrosalpinx. Br J Obstet Gynaecol 1996;103:268-72.
12. Schiller VL, Tsuchiyama K. Development of hydrosalpinx during ovulation induction. J Ultrasound Med 1995;14:799-803.
13. Halbert SA, Patton DL. Hydrosalpinx: effect of oviductal dilatation on egg transport. Fertil Steril 1981;35:69-73.
14. David A, Garcia CR, Czernobilsky B. Human hydrosalpinx: histologic study and chemical composition of fluid. Am J Obstet Gynecol 1969;105:400-11.
15. Ben-Rafael Z, Orvieto R. Cytokines: involvement in reproduction. Fertil Steril 1992;58:1093-9.
16. Verhulst G, Vandersteen N, Van Steirteghem AC, Devroey P. Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme. Hum Reprod 1994;9:624-8.